▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3569 by analyst upside · 2026-06-27
RVTY
Revvity, Inc.
Healthcare · Market Cap $13B · P/E 54.6x
ANALYST PRICE TARGET
+0.6%
implied upside to consensus target
Current Price $113.02
Consensus Target $113.64
Bull Target $145.0
Bear Target $90.0
Analysts Covering 14
ANALYST CONSENSUS — BUY
Strong Buy
2
Buy
5
Hold
6
Sell
1
52-Week Low $81.22
52-Week High $118.3
YTD Return +15.3%
FUNDAMENTALS
Market Cap $13B
P/E Ratio (TTM) 54.6x
Forward P/E 19.4x
EPS (TTM) $2.07
PEG Ratio 0.65
Dividend Yield 0.25%
Revenue (TTM) $2.9B
Profit Margin 8.3%
52-WEEK RANGE
52-Week Low $81.22
52-Week High $118.3
Current Price $113.02
Bear Target $90.0
Bull Target $145.0
● Now $113.02 ● Target $113.64
TRADING DATA
Avg Volume 1.3M
YTD Return +15.3%
Analyst Count 14
Consensus Buy
Upside to Target +0.6%
Last Updated 2026-06-27

ANALYST SUMMARY

Revvity, Inc. (RVTY) is currently trading at $113.02 with a Wall Street consensus price target of $113.64, implying potential upside of 0.6% over the next 12 months. 14 analysts currently cover RVTY, with a consensus rating of Buy — 50% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $145.0, while the most cautious has a target of $90.0.

RVTY operates in the Healthcare sector with a market capitalisation of $13B. The stock is up 15.3% year-to-date and is currently trading near the upper end of its 52-week range of $81.22 – $118.3.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

ICLR +3.2%
ICON Public Limited Company
$13B · P/E 74.8x · Buy
COO +13.4%
The Cooper Companies, Inc.
$14B · P/E 60.2x · Buy
MOH -16.5%
Molina Healthcare, Inc.
$12B · P/E 61.4x · Hold
PEN +15.1%
Penumbra, Inc.
$12B · P/E 72.8x · Hold
RDY -6.9%
Dr. Reddy's Laboratories Limited
$13B · P/E 28.5x · Hold

RECENT ANALYST CALLS

Upgrade/downgrade history for RVTY, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barclays — Reiterated
Equal-Weight → Equal-Weight 2026-05-07 Building track record
JP Morgan — Reiterated
Neutral → Neutral 2026-05-06 43% win rate (7 calls)
TD Cowen — Reiterated
Buy → Buy 2026-05-06 Building track record
Stifel — Reiterated
Hold → Hold 2026-05-06 Building track record
Baird — Reiterated
Outperform → Outperform 2026-05-04 Building track record
Goldman Sachs — Reiterated
Neutral → Neutral 2026-04-14 Building track record
Barclays ↓ Downgrade
Overweight → Equal-Weight 2026-04-14 Building track record
JP Morgan — Reiterated
Neutral → Neutral 2026-03-31 43% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
—
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →